The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Actor Yoo Ah-in appears for questioning over alleged drug use

  • 3

    ANALYSISTesla, BYD's price cuts unnerve LGES, Samsung, SK

  • 5

    Yoo Ah-in appears before police over alleged use of illegal drugs

  • 7

    Will April releases revive Korean cinema? Films to look out for in April

  • 9

    Chun Doo-hwan's grandson apprehended at Incheon Int'l Airport over drug use

  • 11

    One of two Kazakhstanis who fled Incheon Int'l Airport nabbed

  • 13

    N. Korea fires 2 SRBMs toward East Sea; US aircraft carrier due in S. Korea for joint training

  • 15

    Nongshim plans to build plant in eastern US region

  • 17

    Right-wing Japanese support Seoul-Tokyo ties: Korean envoy to Japan

  • 19

    Indonesian investment minister promotes EV cooperation with Korea

  • 2

    SK chief's estranged wife sues his new partner for compensation

  • 4

    4 young Nigerian siblings killed in house fire in Ansan

  • 6

    US aircraft carrier to visit Busan amid NK provocations

  • 8

    Dreams come true: TXT mesmerizes 21,000 fans at KSPO Dome

  • 10

    Korean crypto investors want Do Kwon punished in US

  • 12

    Families of foreign construction workers can receive retirement pay: court

  • 14

    Gimpo-China flights recover to pre-pandemic levels

  • 16

    Local bank stocks hit by shockwaves from SVB, CS collapses

  • 18

    TEMPLE ADVENTURESHaedong Yonggung Temple prospers on Busan's coast

  • 20

    POSCO's 135-day Pohang plant recovery dubbed 'miracle'

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Wed, March 29, 2023 | 06:55
[INTERVIEW] Immunomic Therapeutics CEO expects meaningful test results for brain tumor drug
INTERVIEWImmunomic Therapeutics CEO expects meaningful test results for brain tumor drug
William Hearl, CEO of Immunomic Therapeutics, the U.S. subsidiary of the Korean biotech company, HLB, said that the company expects meaningful test results from its Phase 2 clinical trials of a drug for glioblastoma by August of this year at the latest.
Baek Byung-yeul | 2022-05-26 16:03
HLB gets positive Phase 3 data with liver cancer treatment
HLB gets positive Phase 3 data with liver cancer treatment
HLB has taken a step closer to the global commercialization of its anticancer treatment Rivoceranib as it secured statistical significance in Phase 3 global clinical trials of the drug, according to the local biotech company, Sunday.
Baek Byung-yeul | 2022-05-15 16:23
Lotte seeks to acquire US CMO plant to enter bioindustry
Lotte seeks to acquire US CMO plant to enter bioindustry
Lotte Group is in the process of acquiring a bioindustry contract manufacturing (CMO) plant in the U.S., according to the investment banking industry, Thursday. The move comes after the conglomerate declared the bioindustry as its new growth engine. CMOs specialize in producing biopharmaceuticals developed by other companies.
Kim Hyun-bin | 2022-05-05 14:46
CHA Biotech's US subsidiary opens CDMO plant in Texas
CHA Biotech's US subsidiary opens CDMO plant in Texas
Matica Biotechnology, a U.S. affiliate of CHA Biotech, has opened a cell and gene therapy manufacturing facility in College Station, Texas, according to the cell therapeutics and stem cell developer affiliate of CHA Medical & Bio Group, Wednesday.
Lee Kyung-min | 2022-05-04 15:53
Osstem Implant posts record profits for Q1
Osstem Implant posts record profits for Q1
Osstem Implant posted a record operating profit for the first quarter, the dental equipment manufacturer said Friday.
Baek Byung-yeul | 2022-04-29 16:30
HLB posts earnings surprise in Q1
HLB posts earnings surprise in Q1
Local biotech company HLB posted sales and operating profit records for the first quarter. The company announced on April 25 that its quarterly sales rose a whopping 1,052 percent from the same period in 2021 to 63.4 billion won ($50.8 million). Its operating profit also came to 18.8 billion won to turn into a surplus. Both sales and operating profit figures were the highest ...
Baek Byung-yeul | 2022-04-26 15:12
Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine
Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine
President Moon Jae-in praised a successful Phase 3 trial of the nation's first homegrown COVID-19 vaccine, developed by SK Bioscience, Tuesday.
2022-04-26 15:09
Yoon to visit headquarters of homegrown COVID-19 vaccine
Yoon to visit headquarters of homegrown COVID-19 vaccine
President-elect Yoon Suk-yeol will visit homegrown vaccine producer SK Bioscience on Monday and emphasize vaccine sovereignty amid the country's fight against the novel coronavirus, his spokesperson said.
2022-04-25 10:58
SD Biosensor, Korean COVID-19 test kit maker, to buy Italian firm for 61.9 billion won
SD Biosensor, Korean COVID-19 test kit maker, to buy Italian firm for 61.9 billion won
SD Biosensor, a Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won ($49.8 million) in an effort to tap deeper into the European market.
2022-04-22 15:10
SK bioscience to develop antiviral nasal spray
SK bioscience to develop antiviral nasal spray
SK bioscience, a biotech affiliate of SK Group, said Wednesday that it will develop a spray-type antiviral drug, with research funds provided by the Bill & Melinda Gates Foundation, a private foundation.
Lee Kyung-min | 2022-04-14 09:03
12345 6 78
Top 10 Stories
1Clock ticks for China's massive repatriation of North Korean defectorsClock ticks for China's massive repatriation of North Korean defectors
2Revised Japanese textbooks distort wartime forced labor, catching Korea off guardRevised Japanese textbooks distort wartime forced labor, catching Korea off guard
3Ramsar wetland in Han River cleaned up for protected birdlife Ramsar wetland in Han River cleaned up for protected birdlife
4CJ CheilJedang sees chicken as next big seller after frozen dumplingCJ CheilJedang sees chicken as next big seller after frozen dumpling
5Civic groups in Gwangju await meeting with Chun Doo-hwan's grandson Civic groups in Gwangju await meeting with Chun Doo-hwan's grandson
6Gold price nears all-time high amid financial jitters Gold price nears all-time high amid financial jitters
7BMW launches new XM BMW launches new XM
8North Korea unveils tactical nuclear warheadNorth Korea unveils tactical nuclear warhead
9Jeju seaways get busy with cruise ships, new trade route to Qingdao Jeju seaways get busy with cruise ships, new trade route to Qingdao
102024 budget to focus on tackling low birthrate2024 budget to focus on tackling low birthrate
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group